JPRN-UMIN000005179已完成2 期
Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab - Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Advanced pleural effusion, ascites 2) CNS metastases 3) Infection 4) Diarrhea (watery stool) 5) Heart disease as a clinical problem 6) Severe complications (intestinal paralysis, intestinal obstruction, interstitial pneumonia or pulmonary fibrosis, it is difficult to control diabetes, heart failure, kidney failure, liver failure etc.) 7) Active double cancer 8) Severe mental disorder 9) Irinotecan, oxaliplatin, panitumumab history of hypersensitivity to 10) Treatment with atazanavir sulfate 11) Pregnant and lacting women 12) Severe drug allergy 13) Judged unfit to by doctors in this study
研究者
相似试验
已完成
2 期
Phase II study of panitumumab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancermetastatic colorectal cancerJPRN-UMIN000011440onprofit Organization Japan Clinical Cancer Research Organization35
已完成
2 期
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal CancerColorectal CancerNCT00842257Massachusetts General Hospital20
进行中（未招募）
不适用
Multicenter phase II study of panitumumab, docetaxel, 5-FU, leucovorin and oxaliplatin (P-FLOT) in patients with metastatic or locally advanced Kras wild type adenocarcinoma of the stomach or the gastroesophageal junctioAdenocarcinoma of the stomach or the gastroesophageal junctionMedDRA version: 14.1Level: LLTClassification code 10017768Term: Gastric cancer stage IV without metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10017767Term: Gastric cancer stage IV with metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-018993-20-DEniversitätsklinikum Schleswig-Holstein, Campus Kiel
招募中
不适用
Panitumumab plus mFOLFOX6 therapy for colorectal cancer patients of RAS wild with potential resectable metastases in relation to early tumor shrinkagecolorectal cancer with potential resectable metastasesJPRN-UMIN000012832Chubu Clinical Oncology Group(CCOG)30
终止
1 期
Panitumumab and Bortezomib for Patients With Advanced Colorectal CancerColorectal CancerNCT01504477Georgetown University6